Rob Scott - Chief Medical Officer and Head of Research and Development @ Abionyx Pharma

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Person)

272,088

Primary Job Title Chief Medical Officer and Head of Research and Development
Primary Organization
Abionyx Pharma

Location Chicago, Illinois, United States
Regions Greater Chicago Area, Great Lakes, Midwestern US
Gender Male

Facebook View on Facebook
LinkedIn View on LinkedIn

Rob Scott is the current Chief Medical Officer and Head of Research and Development of Abionyx Pharma. He previously worked at AbbVie as a Chief Medical Officer and Head of Development. Rob Scott attended the University of Cape Town.

Jobs

Number of Current Jobs

Number of Past Jobs

Rob Scott

is the

Chief Medical Officer and Head of Research and Development

Abionyx Pharma

. Additionally,

Rob Scott

has had

past job as the

Chief Medical Officer, Head of Development

AbbVie

Abionyx Pharma Chief Medical Officer and Head of Research and DevelopmentJan 2024

Organization Name	Title At Company	Start Date	End Date
AbbVie	Chief Medical Officer, Head of Development	Apr 1, 2016	May 1, 2020

Board and Advisor Roles

Number of Current Board & Advisor Roles

Rob Scott

holds

board and advisor roles including

Board Member

Redx Pharma

Board Member

Windtree Therapeutics

, and

Board Member

Oncospherix

Redx Pharma Board Member2022
Windtree Therapeutics Board MemberFeb 1, 2021
Oncospherix Board Member2021
Morningside Strategic AdvisorSep 1, 2020
ArisGlobal Board MemberJun 1, 2020
Confo Therapeutics Board MemberJun 1, 2020
Variant Bio Scientific Advisory Board MemberMay 1, 2020
Draupnir Bio Board Member2020
Bioethics International Advisor2017

Related Hubs

Hub Name	CB Rank (Hub)
Biotechnology Public Companies With Fewer Than 50 Employees	24,801
Health Care Public Companies With Fewer Than 50 Employees	28,525
Sofinnova Partners Portfolio Companies	61,035
France 2030 Portfolio Companies	63,975
Biotechnology Public Companies With Fewer Than 100 Employees	16,499
HealthCap Portfolio Companies	95,143
Alta Partners Portfolio Companies	70,198
Biotechnology Public Companies With Less Than $50M in Revenue	13,766
IRDI Portfolio Companies	90,180
TVM Capital Portfolio Companies	89,867